vein graft stenosis
Conditions
Interventions
pitavastatin group
non-statin group
Sponsors
Asahikawa Medical University
Eligibility
Sex/Gender
All
Inclusion criteria
Inclusion criteria: Patients after autogenous arterial reconstructions for ASO and with necessity for any treatment on their LDL cholesterol.
Exclusion criteria
Exclusion criteria: Patients who (1)received revision surgeries over two times within 48 hrs. (2)is unfinished their planned bypass surgery. (3)have took HMG-CoA reductase inhibitor before the bypass surgery. (4)have malignant tumor in active phase. (5)have been undergone PCI or CABG for CAD. (6)meet the contraindication of the drugs using in this study. (7)is undergoing dialysis. (8)cannot stop taking the prohibited drugs in this study. (9)cannot change taking the anti platelet agents to aspirin. (10)are ineligible in the opinion of the investigator.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Primary patency of the vein graft | — |
Secondary
| Measure | Time frame |
|---|---|
| Secondary patency of the vein graft, the number of revision operation times , and occurrence events as below; 1)graft obstruction 2)major amputation 3)overall mortality 4)cardiovascular events 5)stroke | — |
Countries
Japan
Contacts
Public ContactYukihiro Saito
Asahikawa Medical University Department of Vascular Surgery
Outcome results
None listed